Preclinical and in silico data suggest oral enalapril may possess antianxiety properties linked to the GABAergic renin-angiotensin-aldosterone system.
Enalapril demonstrates anxiolytic-like properties, further insights into the GABAergicrenin- angiotensin-aldosterone mechanistic hypothesis.
Filho et al. (Fri,) studied this question.